Langa Kenneth M, Fendrick A Mark, Chernew Michael E, Kabeto Mohammed U, Paisley Kerry L, Hayman James A
Division of General Medicine Department of Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Value Health. 2004 Mar-Apr;7(2):186-94. doi: 10.1111/j.1524-4733.2004.72334.x.
There is currently limited information regarding the out-of-pocket expenditures (OOPE) for medical care made by elderly individuals with cancer. We sought to quantify OOPE for community-dwelling individuals age 70 or older with: 1) no cancer (No CA), 2) a history of cancer, not undergoing current treatment (CA/No Tx), and 3) a history of cancer, undergoing current treatment (CA/Tx).
We used data from the 1995 Asset and Health Dynamics Study, a nationally representative survey of community-dwelling elderly individuals. Respondents identified their cancer status and reported OOPE for the prior 2 years for: 1) hospital and nursing home stays, 2) outpatient services, 3) home care, and 4) prescription medications. Using a multivariable two-part regression model to control for differences in sociodemographics, living situation, functional limitations, comorbid chronic conditions, and insurance coverage, the additional cancer-related OOPE were estimated.
Of the 6370 respondents, 5382 (84%) reported No CA, 812 (13%) reported CA/No Tx, and 176 (3%) reported CA/Tx. The adjusted mean annual OOPE for the No CA, CA/No Tx, and CA/Tx groups were 1210 dollars, 1450 dollars, and 1880 dollars, respectively (P < .01). Prescription medications (1120 dollars per year) and home care services (250 dollars) accounted for most of the additional OOPE associated with cancer treatment. Low-income individuals undergoing cancer treatment spent about 27% of their yearly income on OOPE compared to only 5% of yearly income for high-income individuals with no cancer history (P < .01).
Cancer treatment in older individuals results in significant OOPE, mainly for prescription medications and home care services. Economic evaluations and public policies aimed at cancer prevention and treatment should take note of the significant OOPE made by older Americans with cancer.
目前关于老年癌症患者自付医疗费用(OOPE)的信息有限。我们试图对70岁及以上社区居住个体的自付医疗费用进行量化,这些个体分为:1)无癌症(无CA),2)有癌症病史但目前未接受治疗(CA/未治疗),3)有癌症病史且目前正在接受治疗(CA/治疗)。
我们使用了1995年资产与健康动态研究的数据,这是一项对社区居住老年个体具有全国代表性的调查。受访者确定其癌症状况,并报告前两年在以下方面的自付医疗费用:1)住院和养老院护理,2)门诊服务,3)家庭护理,4)处方药。使用多变量两部分回归模型来控制社会人口统计学、生活状况、功能限制、合并慢性病和保险覆盖方面的差异,估计与癌症相关的额外自付医疗费用。
在6370名受访者中,5382人(84%)报告无CA,812人(13%)报告CA/未治疗,176人(3%)报告CA/治疗。无CA、CA/未治疗和CA/治疗组的调整后平均年度自付医疗费用分别为1210美元、1450美元和1880美元(P <.01)。处方药(每年1120美元)和家庭护理服务(250美元)占与癌症治疗相关的额外自付医疗费用的大部分。接受癌症治疗的低收入个体将其年收入的约27%用于自付医疗费用,而无癌症病史的高收入个体仅将年收入的5%用于自付医疗费用(P <.01)。
老年个体的癌症治疗导致大量的自付医疗费用,主要用于处方药和家庭护理服务。旨在癌症预防和治疗的经济评估和公共政策应注意到美国老年癌症患者的大量自付医疗费用。